Alps Advisors Inc Edwards Lifesciences Corp Transaction History

Alps Advisors Inc

$17.2 Billion
Q1 2025

A detailed history of Alps Advisors Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Alps Advisors Inc holds 5,090 shares of EW stock, worth $398,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,090

Holding current value

$398,139

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$67.95 - $76.19 $345,865 - $387,807	5,090 New	5,090 $368,000
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $18,081 - $22,783	-293 Reduced 6.51%	4,211 $321,000
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $16,211 - $21,850	234 Added 5.48%	4,504 $312,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $2,442 - $2,829	30 Added 0.71%	4,270 $402,000
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $314,862 - $358,322	4,240 New	4,240 $350,000
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $2,941 - $4,361	-34 Reduced 1.04%	3,248 $309,000
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $24,470 - $30,801	240 Added 7.89%	3,282 $386,000
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $3,935 - $4,835	37 Added 1.23%	3,042 $394,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $120,301 - $143,494	-1,169 Reduced 28.01%	3,005 $340,000
Q1 2021 May 07, 2021	BUY	$78.68 - $90.67 $328,410 - $378,456	4,174 New	4,174 $349,000
Q3 2020 Nov 04, 2020	SELL	$67.19 - $87.44 $231,536 - $301,318	-3,446 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $124,919 - $167,058	2,171 Added 170.27%	3,446 $238,000
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $16,718 - $25,839	-319 Reduced 20.01%	1,275 $240,000
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $4,947 - $5,664	-69 Reduced 4.15%	1,594 $372,000
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $289,777 - $355,124	-4,708 Reduced 73.9%	1,663 $366,000
Q2 2019 Aug 07, 2019	SELL	$55.74 - $64.41 $42,808 - $49,466	-768 Reduced 10.76%	6,371 $1.18 Million
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $21,167 - $28,310	-442 Reduced 5.83%	7,139 $1.37 Million
Q4 2018 Feb 04, 2019	BUY	$46.41 - $56.94 $510 - $626	11 Added 0.15%	7,581 $1.16 Million
Q3 2018 Oct 25, 2018	BUY	$45.7 - $58.03 $158,396 - $201,131	3,466 Added 84.45%	7,570 $1.32 Million
Q2 2018 Jul 25, 2018	BUY	$42.45 - $51.3 $174,214 - $210,535	4,104 New	4,104 $463,000
Q1 2018 May 01, 2018	SELL	$37.19 - $47.45 $152,627 - $194,734	-4,104 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $148,934 - $159,358	4,104	4,104 $449,000

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

487M

Call Options Held

2.77M

Put Options Held

2.05M

Vanguard Group Inc Valley Forge, PA

69.2M
Shares

$5.41 Billion
0.09% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.99 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

29.1M
Shares

$2.28 Billion
0.42% of portfolio
State Street Corp Boston, MA

25.8M
Shares

$2.02 Billion
0.08% of portfolio
Jpmorgan Chase & CO New York, NY

22M
Shares

$1.72 Billion
0.12% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account